Prospective Observational Study on Infants and children with Acute Diarrhoea treated with gelatine tannate.
Durban Reguera F. et al. Presented as a poster in the congress “Semana de las Enfermedades Digestivas” in Madrid (Spain), June 2007. [...]
Gelatine Tannate for the treatment of Acute Diarrhoea in Adults.
Allegrini A. & Constantini M. J Gastroint Dig Syst 2012, 2:3. Abstract: Gelatine tannate has been recently licensed as a medical device for the treatment of acute diarrhoea. Gelatine tannate is thought to act locally on the gut wall by forming a protective protein-based film and allowing the precipitation of [...]
Prospective Observational Study on Adults with Acute Diarrhoea treated with gelatine tannate.
Durban Reguera F. et al. Presented as a poster in the congress “Semana de las Enfermedades Digestivas” in Madrid (Spain), June 2007. [...]
New insights into the mechanism of action of gelatine tannate for acute diarrhoea. Part 2: antibacterial activity.
De Servi B, et al. Presented at GFHGHP 2012. Presented as oral communication at the 33rd edition of the Congress from the Groupe Francophone d’Hépato-Gastroentérologie et Nutrition Pédiatriques, Nantes (France),March 2012. Abstract: New insights into the mechanism of action of gelatine tannate for acute diarrhoea. Part 2: antibacterial activity. De [...]
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.
L.R. Lopetuso, F. Scaldaferri, G. Bruno, V. Petito, F. FranceschI, A. Gasbarrini. European Review for Medical and Pharmacological Sciences. 2015; 19: 1068-1076 Objective: Gut barrier is a functional unit organized as a multi-layer system and its multiple functions are crucial for maintaining gut homeostasis. Numerous scientific evidences showed a significant [...]
Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.
Lucio Gnessi, Xavier Llop, Núria Piqué. 23rd UEG WEEK BARCELONA. October 24-28 2015 [...]
Undissociated gelatine tannate and xyloglucan prevent gut leakiness and mucosal inflammation induced by LPS: insights in the mechanism of action.
H. Eutamene. P1449. UEG journal. October 2016. Vol 4. Suppl. 1 Pag A651 Introduction: Gelatine tannate (GT) and xylogucan (XG) are commercially available in several countries for the oral treatment of diarrhea in children and adults. However, the mechanism of action remains poorly understood. Aims & Methods: Therefore, we aimed to [...]
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD?
Franco Scaldaferri Loris Riccardo Lopetuso1, Valentina Petito, et al. United European Gastroenterology Journal 2014, Vol. 2(2) 113–122 Background: Gelatin tannate, a gelatin powder containing tannic acids, is commonly employed as an intestinal astringent. Neither information nor animal model exist to confirm its efficacy or unravel mechanisms of action. Objective: To [...]
Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.
Lucio Gnessi, Vladimir Bacarea, Marius Marusteri and Núria Piqué. BMC Gastroenterology (2015) 15:153 Background: There is a strong rationale for the use of agents with film-forming protective properties, like xyloglucan, for the treatment of acute diarrhea. However, few data from clinical trials are available. Methods: A randomized, controlled, open-label, parallel [...]
CPHI 2025
Frankfurt, Germany 20-30 October 2025 Noventure will attend the CPHI (Frankfurt, 28-30 October 2025) Arrange a meeting with us to learn more about our products and license availability in the different countries. ¡Meet us at our Stand #4.1L30! Contact us: https://noventure.com/contact-us Event site [...]